These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24146249)

  • 1. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study.
    Di Minno MN; Dentali F; Lupoli R; Ageno W
    Circulation; 2014 Jan; 129(4):497-503. PubMed ID: 24146249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
    Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study.
    Baglin T; Luddington R; Brown K; Baglin C
    Lancet; 2003 Aug; 362(9383):523-6. PubMed ID: 12932383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Antithrombin, subtype of antithrombin deficiency and the risk of venous thromboembolism in hereditary antithrombin deficiency: A family cohort study.
    Croles FN; Mulder R; Mulder AB; Lukens MV; Meijer K
    Thromb Res; 2018 Aug; 168():47-52. PubMed ID: 29902631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of recurrent venous thromboembolism among young women after a first event while exposed to combined oral contraception versus not exposed to: a cohort study.
    Le Moigne E; Delluc A; Tromeur C; Nowak E; Mottier D; Lacut K; Le Gal G
    Thromb Res; 2013 Jul; 132(1):51-5. PubMed ID: 23786893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilia and risk of VTE recurrence according to the age at the time of first VTE manifestation.
    Weingarz L; Schindewolf M; Schwonberg J; Hecking C; Wolf Z; Erbe M; Lindhoff-Last E; Linnemann B
    Vasa; 2015 Jul; 44(4):313-23. PubMed ID: 26314364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency.
    Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E
    Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-specific risk factors for recurrent venous thromboembolism.
    Olié V; Zhu T; Martinez I; Scarabin PY; Emmerich J
    Thromb Res; 2012 Jul; 130(1):16-20. PubMed ID: 22100316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B blood group: A strong risk factor for venous thromboembolism recurrence.
    Baudouy D; Moceri P; Chiche O; Bouvier P; Schouver ED; Cerboni P; Gibelin P; Ferrari E
    Thromb Res; 2015 Jul; 136(1):107-11. PubMed ID: 25981188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S.
    De Stefano V; Simioni P; Rossi E; Tormene D; Za T; Pagnan A; Leone G
    Haematologica; 2006 May; 91(5):695-8. PubMed ID: 16670075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies.
    Di Minno MN; Ambrosino P; Ageno W; Rosendaal F; Di Minno G; Dentali F
    Thromb Res; 2015 May; 135(5):923-32. PubMed ID: 25784135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.
    Schulman S; Kakkar AK; Goldhaber SZ; Schellong S; Eriksson H; Mismetti P; Christiansen AV; Friedman J; Le Maulf F; Peter N; Kearon C;
    Circulation; 2014 Feb; 129(7):764-72. PubMed ID: 24344086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
    Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
    Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S; Heinze G; Jandeck LM; Kyrle PA
    Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for recurrence of venous thromboembolism associated with the use of oral contraceptives.
    Vaillant-Roussel H; Ouchchane L; Dauphin C; Philippe P; Ruivard M
    Contraception; 2011 Nov; 84(5):e23-30. PubMed ID: 22018134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence and clinical manifestation of hereditary thrombophilia in Korean patients with unprovoked venous thromboembolisms.
    Lee SY; Kim EK; Kim MS; Shin SH; Chang H; Jang SY; Kim HJ; Kim DK
    PLoS One; 2017; 12(10):e0185785. PubMed ID: 29040284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.